The online version of this article (doi:10.1186/1477-7819-10-19) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
ID: preparation and drafting of the manuscript, literature research; SH: editing of the manuscript; AK: editing of the manuscript; BK: immunohistochemical staining and examination of the specimen, editing of the manuscript; MF: editing of the manuscript; HJ: editing of the manuscript. All authors read and approved the final manuscript.
Overdiagnosis of bronchopulmonary carcinoid tumors together with overtreatment can cause serious postoperative consequences for the patient. We report of a patient with a typical bronchopulmonary carcinoid tumor, which was initially misdiagnosed and treated as an adenocarcinoma of the lung. GnrH receptors and the associated Raf-1/MEK/ERK-1/2-pathway are potential targets for analogs in cancer treatment. We suspected a correlation between the lack of tumor growth, application of leuprolide and the Raf-1/MEK/ERK-1/2-pathway. Therefore, we examined GnrH receptor status in the examined specimen.
In 2010 a 77 year-old male patient was shown to have a tumor mass of about 1.7 cm diameter in the inferior lobe of the left lung. Since 2005, this tumor had hitherto been known and showed no progression in size. The patient suffered from prostate cancer 4 years ago and was treated with TUR-P, radiation therapy and the application of leuprolide. We conducted an explorative thoracotomy with atypical segment resection. The first histological diagnosis was a metastasis of prostate cancer with lymphangiosis carcinomatosa. After several immunohistochemical stainings, the diagnosis was changed to adenocarcinoma of the lung. We conducted a re-thoracotomy with lobectomy and systematic lymphadenectomy 12 days later. The tumor stage was pT1 N0 MX G2 L1 V0 R0. Further immunohistochemical studies were performed. We received the results 15 days after the last operation. The diagnosis was ultimately changed to typical carcinoid tumor without any signs of lymphatic vessel invasion. The patient recovered well from surgery, but still suffers from dyspnea and lack of physical performance. Lung function testing revealed no evidence of impairment.
The use of several immunohistochemical markers, careful evaluation of hematoxylin-eosin sections and the Ki-67 labelling index are important tools in discriminating between carcinoids and other bronchopulmonary carcinomas. Although we could not detect GnrH-receptors in the examined specimen, there may be individual differences in expression. GnrH receptor profiles in typical and atypical carcinoids should be scrutinized. This could lead to new therapeutical options, since the GnrH receptor has already been described on atypical carcinoids. Clinically tested drugs such as leuprolide could come to use.
Laennec RTH: Traite de l'auscultation mediate et des maladies des poumons et du coer. Paris: J.S. Chaudé. 1831
Mueller H: Zur Entstehungsgeschichte der Bronchialerweiterungen. MD thesis. 1882, University of Halle, Faculty of Medicine
Lubarsch O: Über den primären Krebs des Ileums nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberkulose. Virchows Arch Pathol Anat Physiol Klin Med. 1888, 111: 280-317. 10.1007/BF01966242. CrossRef
Oberndorfer S: Karzinoide Tumoren des Dünndarms. Frankf Z Pathol. 1907, 1: 426-430.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB: One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008, 26: 3063-72. 10.1200/JCO.2007.15.4377. CrossRefPubMed
García-Yuste M, Matilla JM, Cueto A, Paniagua JM, Ramos G, Cañizares MA, Muguruza I: Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg. 2007, 31: 192-7. 10.1016/j.ejcts.2006.11.031. CrossRefPubMed
Gould VE, Linnoila RI, Memoli VA, Warren WH: Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest. 1983, 49: 519-37. PubMed
Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972, 64: 413-21. PubMed
Hamperl H: Über gutartige Bronchialtumoren (Cylindrome und Carcinoide). Virchows Arch Pathol Anat Physiol Klin Med. 1937, 300: 46-88. 10.1007/BF01888109. CrossRef
Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC: Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization classification of tumours. Edited by: Kleihues P, Sobin LH. 2004, Lyon: IARC Press
Rekhtman N: Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010, 134: 1628-38. PubMed
Davini F, Gonfiotti A, Comin C, Caldarella A, Mannini F, Janni A: Typical and atypical carcinoid tumours: 20-year experience with 89 patients. J Cardiovasc Surg (Torino). 2009, 50: 807-11.
Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Präuer HW, Werner M, Höfler H: Typical and atypical carcinoid tumors of the lung are characterized by 11 q deletions as detected by comparative genomic hybridization. Am J Pathol. 1998, 153: 1089-98. 10.1016/S0002-9440(10)65653-2. PubMedCentralCrossRefPubMed
Matoso A, Singh K, Jacob R, Greaves WO, Tavares R, Noble L, Resnick MB, Delellis RA, Wang LJ: Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010, 18: 142-9. 10.1097/PAI.0b013e3181bdf4e7. PubMedCentralCrossRefPubMed
Sturm N, Rossi G, Lantuejoul S, Papotti M, Frachon S, Claraz C, Brichon PY, Brambilla C, Brambilla E: Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol. 2002, 33: 175-82. 10.1053/hupa.2002.31299. CrossRefPubMed
Sampietro G, Tomasic G, Collini P, Biganzoli E, Boracchi P, Bidoli P, Pilotti S: Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol. 2000, 8: 49-56. 10.1097/00022744-200003000-00008. CrossRefPubMed
Folpe AL, Gown AM, Lamps LW, Garcia R, Dail DH, Zarbo RJ, Schmidt RA: Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol. 1999, 12: 5-8. PubMed
Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, Weidner N, Yi ES: TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol. 2004, 35: 825-31. 10.1016/j.humpath.2004.02.016. CrossRefPubMed
Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale S, Zilembo N, Di Bartolomeo M, Seregni E, Bombardieri E: Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 1999, 86: 858-65. 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8. CrossRefPubMed
Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW: Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab. 1997, 82: 2622-8. 10.1210/jc.82.8.2622. PubMed
Jadvar H, Segall GM: False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med. 1997, 38: 1382-3. PubMed
Suemitsu R, Maruyama R, Nishiyama K, Okamoto T, Wataya H, Seto T, Ichinose Y: Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report. Ann Thorac Cardiovasc Surg. 2008, 14: 109-11. PubMed
Belak J, Kudlac M, Zak V, Cavarga I, Kocan P, Böör A, Stebnicky M, Somos A, Tkacova R: Surgical management of bronchopulmonary carcinoid tumors: experience over 8 years and review of the literature. Tumori. 2010, 96: 84-9. PubMed
Martini N, Zaman MB, Bains MS, Burt ME, McCormack PM, Rusch VW, Ginsberg RJ: Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. J Thorac Cardiovasc Surg. 1994, 107: 1-7. PubMed
- Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II